JOIN THE MOVEMENT Share your Managed Care Pharmacy superpower and photo with #WeAreMCPs Learn more Close
Announcing Daria Sinclair

Empowering Change: AMCP Foundation Partners with Moda Health and ...

AMCP Foundation partners with Moda Health and Novo Nordisk Inc., launching a Health Disparities Research Internship and selects Daria Sinclair of Howard University to be the first Health Disparities Research Intern.

3/25/24
AMCP Caragon

AMCP Comments on Medicare Prescription Payment Plan: Draft Part T...

On Feb. 15, 2024, the Centers for Medicare and Medicaid Services (CMS) issued the Medicare Prescription Payment Plan: Draft Part Two Guidance and a Fact Sheet to provide guidance on education and outreach requirements for the Medicare Prescription Payment Plan (M3P), which was established by the Inflation Reduction Act (IRA). AMCP submitted comments in response to this Guidance on March 15, 2024.

3/15/24
AMCP Caragon

An Investigational Targeted Treatment for mIDH Glioma

A Pre-Approval Information Exchange (PIE) Webinar, sponsored by Servier.

Iulia Opran

AMCP Names Iulia Opran 2024-2025 Executive Fellow in Health Care ...

AMCP has chosen Iulia Opran, a PharmD/MS candidate, as its 2024–2025 Executive Fellow in Health Care Association Leadership. Her diverse pharmacy background and passion for managed care make her a valuable addition to the program, which begins on July 1, 2024.

3/14/24
AMCP Caragon

The Evolution of Care for IBD Patients

A Science & Innovation Webinar, sponsored by Abbvie.

AMCP Caragon

AMCP Comments on Impacts of the Cyberatack on Change Healthcare

In a March 5, 2024 press release, the Department of Health & Human Services (HHS) expressed intent to issue guidance to encourage Medicare Advantage (MA) and Part D plans to relax or remove prior authorization requirements and other utilization management strategies. On March 6, 2024, CMS issued a memo encouraging MA and Part D plans to relax or remove prior authorization requirements in response to the Change Healthcare cyberatack. AMCP sent a letter in response to this guidance on March 8, 2024.

3/8/24
AMCP Caragon

AMCP Comment on Draft CY 2025 Part D Redesign Program Instruction...

On January 31, 2024, the Centers for Medicare & Medicaid Services (CMS) issued the Draft Guidance titled “Draft Part D Redesign Program Instructions (Program Instructions)”, concurrently with the Advance Notice. The Draft Part D Redesign Program Instructions provide draft guidance regarding the implementation of certain Inflation Reduction Act (IRA) provisions relating to the Part D drug benefit. CMS is soliciting comments on all aspects of the Guidance, and notes that policies established in the final Guidance are for 2025. AMCP submitted comments in response to this rule on March 1, 2024.

3/1/24
AMCP Caragon

AMCP Comment on Advance Notice of Methodological Changes for Cale...

On January 31, 2024, the Centers for Medicare & Medicaid Services (CMS) issued a proposed rule titled “Advance Notice of Methodological Changes for Calendar Year (CY) 2025”. Each year, CMS is required to update MA payment rates and regularly conducts technical updates through the Advance Notice and Rate Announcement process. AMCP submitted comments in response to this rule on March 1, 2024.

3/1/24
AMCP Caragon

Machine Learning for Kidney Disease

A Science & Innovation Webinar, sponsored by Boehringer Ingelheim.